New York & Tri-State + Uptown/Bronx + Healthcare | July 14, 2022

Hemogenyx Opens R&D Facility in Manhattanville Factory District

Hemogenyx Pharmaceuticals has opened its new custom-engineered R&D facility at Janus Property Company’s Mink Building in West Harlem’s Manhattanville Factory District, adjacent to Columbia University and City College. The company’s research facility includes approximately 10,000 square feet of purpose-built lab space including two clean rooms for cell therapy manufacturing.

Along with continuing and expanding its research, Hemogenyx, which is traded on the London Stock Exchange, can now manufacture cells in-house, accelerating and simplifying the commercialization of its major cell therapy product candidates. The company will use its clean rooms to produce its HEMO-CAR-T cell therapy for treating acute myeloid leukemia.

“It is exciting each time a new tenant opens here,” said Janus principal Scott Meztner. “With Hemogenyx Pharmaceuticals beginning work in such a highly specialized lab that required two clean rooms, the Manhattanville Factory District continues to deliver on its masterplan of becoming New York’s premier life science ecosystem.”

Connect

Inside The Story

Janus Property Company

About Paul Bubny

Paul Bubny serves as Senior Content Director for Connect Commercial Real Estate, a role to which he brings 13-plus years’ experience covering the commercial real estate industry and 30-plus years in business-to-business journalism. In this capacity, he oversees daily operations while also reporting on both local/regional markets and national trends, covering individual transactions across all property types, as well as delving into broader subject matter. He produces 15-20 daily news stories per day and works with the Connect team and clients to develop longer-form content, ranging from Q&As to thought-leadership pieces. Prior to joining Connect, Paul was Managing Editor for both Real Estate Forum and GlobeSt.com at American Lawyer Media, where he oversaw operations at both publications while also producing daily news and feature-length articles. His tenure in B2B publishing stretches back into the print era, and he has served as Editor in Chief on four national trade publications. Since 1999, Paul has volunteered as the newsletter editor of passenger rail advocacy groups (one national, one local).

Order Reprints